Literature DB >> 19012691

Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia.

Fabiana Bernardi1, Francieli Guolo, Thaize Bortolin, Fabricia Petronilho, Felipe Dal-Pizzol.   

Abstract

AIM: Although previous investigators have demonstrated the presence of oxidative stress and inflammation in preeclampsia, none directly correlate both to preeclampsia.
METHODS: We determined in 35 preeclamptic and 35 normotensive pregnant women plasma levels of thiobarbituric acid reactive species, protein carbonyl, tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6 and IL-10.
RESULTS: Plasma thiobarbituric acid reactive species and protein carbonyls were higher in preeclamptic patients. TNF-alpha and IL-6 (but not IL-1beta or IL-10) were higher in preeclamptic patients. We found significant correlation between plasma IL-6 and carbonyls, and these correlated to blood pressure.
CONCLUSIONS: We demonstrated that some oxidative and inflammatory mediators were altered in preeclampsia, and some correlated to blood pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012691     DOI: 10.1111/j.1447-0756.2008.00803.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  23 in total

Review 1.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

2.  Preeclampsia and Sleep-Disordered Breathing: A Case-Control Study.

Authors:  Francesca L Facco; Justin Lappen; Courtney Lim; Phyllis C Zee; William A Grobman
Journal:  Pregnancy Hypertens       Date:  2013-04       Impact factor: 2.899

3.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

4.  Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy.

Authors:  J de Castro; J Sevillano; J Marciniak; R Rodriguez; C González-Martín; M Viana; O H Eun-suk; S Hauguel de Mouzon; E Herrera; M P Ramos
Journal:  Endocrinology       Date:  2011-09-13       Impact factor: 4.736

5.  Psychiatric symptoms and proinflammatory cytokines in pregnancy.

Authors:  Emma Robertson Blackmore; Jan A Moynihan; David R Rubinow; Eva K Pressman; Michelle Gilchrist; Thomas G O'Connor
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

6.  Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter.

Authors:  Christoph Jan Wruck; Konrad Streetz; Goran Pavic; Mario E Götz; Mersedeh Tohidnezhad; Lars-Ove Brandenburg; Deike Varoga; Oliver Eickelberg; Thomas Herdegen; Christian Trautwein; Kaimin Cha; Yuet Wai Kan; Thomas Pufe
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

7.  The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum.

Authors:  Ping Zhou; Xin Luo; Hong-Bo Qi; Wen-Jun Zong; Hua Zhang; Dan-Dan Liu; Qing-Shu Li
Journal:  Inflamm Res       Date:  2012-06-20       Impact factor: 4.575

Review 8.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

9.  Correlation of Plasma Neutrophil Elastase Activity and Endogenous Protease Inhibitor Levels with the Severity of Pre-eclampsia.

Authors:  Mamatha Kunder; Av Moideen Kutty; V Lakshmaiah; S R Sheela
Journal:  J Clin Diagn Res       Date:  2017-03-01

10.  Prepregnancy Vascular Dysfunction in Women who Subsequently Develop Hypertension During Pregnancy.

Authors:  Sarah A Hale; Gary J Badger; Carole McBride; Ronald Magness; Ira M Bernstein
Journal:  Pregnancy Hypertens       Date:  2013-04-01       Impact factor: 2.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.